NexGel Inc (NXGL)

4.70 -0.09 (-1.88%) USD  |  NASDAQ  |  Dec 27, 16:00
4.58 -0.12 (-2.55%) After-Hours: 20:00
More

NexGel Research and Development Expense (Quarterly): 0.00 for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for NXGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
The Cooper Companies Inc 37.70M
Staar Surgical Co 14.50M
OrthoPediatrics Corp 2.577M
Innovative Eyewear Inc 0.1314M
Perspective Therapeutics Inc 12.03M